An In Vitro Investigation Of The Effects Of Formoterol On Thyroid Hormone-Related Gene Expression During Myogenesis by Guerin, Gena D et al.
 
International Journal of Exercise Science                                                             www.tacsm.org 
TACSM Abstract  
 
An In Vitro Investigation Of The Effects Of Formoterol On Thyroid 
Hormone-Related Gene Expression During Myogenesis  
 
GENA D. GUERIN, RYAN A. GORDON, EMILY L. ZUMBRO, and ANTHONY A. 
DUPLANTY  
 
Exercise Physiology Lab; College of Health Promotion and Kinesiology; Texas Woman’s 








Thyroid hormone (TH) is a primary driver of skeletal muscle (SKM) metabolism as well as myogenesis 
through stimulation its genetic targets. The conversion and activation of thyroid hormone (T4 to T3) is 
controlled by local deiodinase 2 and 3 (DIO2, DIO3) activity. This leads to expression of nuclear receptors 
in promotor regions of specific genes including sarco/endoplasmic reticulum calcium ATPase 1(SERCA1), 
which is important for homeostasis of calcium regulation during muscle contraction. PURPOSE: The 
purpose of the study was to examine the effects of the exercise mimetic Formoterol (FORM), a beta-
adrenergic receptor agonist, on the expression of thyroid hormone-related genes during myogenesis In 
Vitro. METHODS: Commercially obtained, primary, human SKM myoblasts (n = 4) were cultured and 
differentiated for one day before initiation of daily treatment of 30 nM FORM or vehicle, dimethyl 
sulfoxide (DMSO) which continued until day 6 of differentiation. Total RNA was extracted on one day 
(D1), four days (D4), and six days (D6) post differentiation. Gene expression for DIO2, DIO3, SERCA1, 
SERCA2, thyroid hormone receptor α (THRα), and thyroid hormone receptor β (THRβ) was analyzed by 
qPCR. RESULTS: Expression of DIO2 decreased from D1 to D4 for both DMSO (P<0.001) and FORM 
(P<0.05). Similarly, DIO2 decreased from D1 to D6 for both DMSO (P<0.001) and FORM (P<0.001) 
treatment. DIO3 expression decreased from D1 to D6 for both DMSO and FORM (P<0.05) treatments. 
THRα expression decreased from D1 to D4 for both DMSO (P<0.05) and FORM (P<0.001). THRβ 
expression decreased from D1 to D6 for both DMSO and FORM (P<0.05). SERCA1 expression only 
decreased for DMSO between D1 and D6 (P<0.05). No differences were found for SERCA2. 
CONCLUSION: Conversion of TH by DIO2 and DIO3 is an important mechanism regulating proliferation 
and differentiation during myogenesis. During cell culture, cells do not receive signals for activity as 
found In Vivo, thus mimicking sedentary behavior and resulting in decreased thyroid hormone related 
gene expression. In our study, FORM appeared to prevent the decrease found for SERCA1 expression in 
the DMSO treatment, indicating that “exercise” stimulation can increase or maintain calcium pump 
activity as compared to “sedentary” muscle conditions. It is possible that exercise stimulates the 
expression of genes related to TH signaling and metabolism during myogenesis. Future studies with 
Formoterol treatment will explore additional treatment timelines and genetic targets for analysis. 
  
 
 
 
